Informations techniques
Exploitant
UCB PHARMA S.A.
Présentation
RYSTIGGO 140 mg/mL, solution injectable par voie sous-cutanée
1 flacon en verre de 2 ml (CIP : 34009 302 847 4 2)
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
FmrngTH0ddsGxtJf